Signature Estate & Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $934K | Buy |
38,803
+14,196
| +58% | +$371K | 0.02% | 280 |
|
|
2026
Q1 | $691K | Sell |
24,607
-721
| -3% | -$19.2K | 0.01% | 356 |
|
|
2025
Q4 | $631K | Buy |
25,328
+1,002
| +4% | +$25.3K | 0.01% | 345 |
|
|
2025
Q3 | $620K | Buy |
24,326
+1,350
| +6% | +$33.3K | 0.01% | 344 |
|
|
2025
Q2 | $557K | Buy |
22,976
+3,722
| +19% | +$86.8K | 0.01% | 345 |
|
|
2025
Q1 | $488K | Buy |
19,254
+486
| +3% | +$12.7K | 0.01% | 343 |
|
|
2024
Q4 | $498K | Sell |
18,768
-68
| -0.4% | -$1.84K | 0.01% | 330 |
|
|
2024
Q3 | $545K | Sell |
18,836
-2,558
| -12% | -$74.6K | 0.01% | 291 |
|
|
2024
Q2 | $599K | Buy |
21,394
+11,010
| +106% | +$303K | 0.02% | 268 |
|
|
2024
Q1 | $288K | Sell |
10,384
-225
| -2% | -$6.24K | 0.01% | 145 |
|
|
2023
Q4 | $305K | Sell |
10,609
-2,134
| -17% | -$64.5K | 0.01% | 146 |
|
|
2023
Q3 | $423K | Sell |
12,743
-26
| -0.2% | -$919 | 0.01% | 129 |
|
|
2023
Q2 | $468K | Buy |
12,769
+5,873
| +85% | +$229K | 0.02% | 126 |
|
|
2023
Q1 | $281K | Buy |
6,896
+180
| +3% | +$7.77K | 0.01% | 150 |
|
|
2022
Q4 | $344K | Buy |
6,716
+335
| +5% | +$16.1K | 0.01% | 146 |
|
|
2022
Q3 | $279K | Sell |
6,381
-1,507
| -19% | -$73.2K | 0.01% | 140 |
|
|
2022
Q2 | $413K | Buy |
7,888
+1,554
| +25% | +$79.2K | 0.02% | 120 |
|
|
2022
Q1 | $328K | Sell |
6,334
-2,167
| -25% | -$112K | 0.02% | 129 |
|
|
2021
Q4 | $502K | Buy |
8,501
+17
| +0.2% | +$842 | 0.02% | 114 |
|
|
2021
Q3 | $365K | Buy |
8,484
+69
| +0.8% | +$3.06K | 0.02% | 128 |
|
|
2021
Q2 | $329K | Sell |
8,415
-98
| -1% | -$3.81K | 0.01% | 131 |
|
|
2021
Q1 | $308K | Sell |
8,513
-1,291
| -13% | -$45.8K | 0.02% | 133 |
|
|
2020
Q4 | $361K | Buy |
9,804
+1,234
| +14% | +$45.3K | 0.02% | 122 |
|
|
2020
Q3 | $298K | Buy |
8,570
+1,137
| +15% | +$39.9K | 0.02% | 126 |
|
|
2020
Q2 | $231K | Buy |
+7,433
| New | +$253K | 0.02% | 130 |
|
|
2020
Q1 | – | Sell |
-7,540
| Closed | -$280K | – | 152 |
|
|
2019
Q4 | $280K | Sell |
7,540
-1,379
| -15% | -$49.1K | 0.02% | 137 |
|
|
2019
Q3 | $304K | Buy |
8,919
+3,660
| +70% | +$133K | 0.02% | 130 |
|
|
2019
Q2 | $216K | Sell |
5,259
-310
| -6% | -$12.3K | 0.01% | 145 |
|
|
2019
Q1 | $225K | Buy |
5,569
+26
| +0.5% | +$1.04K | 0.02% | 147 |
|
|
2018
Q4 | $230K | Buy |
5,543
+332
| +6% | +$13.8K | 0.02% | 136 |
|
|
2018
Q3 | $218K | Buy |
5,211
+920
| +21% | +$35.4K | 0.02% | 117 |
|
|
2018
Q2 | $148K | Sell |
4,291
-680
| -14% | -$23.2K | 0.01% | 139 |
|
|
2018
Q1 | $167K | Sell |
4,971
-1,455
| -23% | -$50K | 0.02% | 130 |
|
|
2017
Q4 | $221K | Buy |
6,426
+286
| +5% | +$9.75K | 0.02% | 134 |
|
|
2017
Q3 | $208K | Sell |
6,140
-637
| -9% | -$20.5K | 0.02% | 126 |
|
|
2017
Q2 | $216K | Sell |
6,777
-1,673
| -20% | -$52.8K | 0.03% | 120 |
|
|
2017
Q1 | $274K | Buy |
8,450
+3,710
| +78% | +$117K | 0.03% | 125 |
|
|
2016
Q4 | $146K | Sell |
4,740
-105
| -2% | -$3.21K | 0.02% | 133 |
|
|
2016
Q3 | $156K | Sell |
4,845
-1,700
| -26% | -$56.8K | 0.02% | 133 |
|
|
2016
Q2 | $219K | Buy |
+6,545
| New | +$209K | 0.04% | 110 |
|
|
2013
Q3 | – | Sell |
-116,196
| Closed | -$3.09M | – | 57 |
|
|
2013
Q2 | $3.09M | Buy |
+116,196
| New | +$3.21M | 2.22% | 19 |
|
Other funds holding PFE
Signature Estate & Investment Advisors's PFE Position: Q2 2026 in Review
Signature Estate & Investment Advisors increased its Pfizer (PFE) stake by 58% in Q2 2026, buying an estimated $371K and bringing the position to 38,803 shares worth $934K. The position accounts for 0.02% of the portfolio, ranked #280.
Signature Estate & Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $3.09M in Q2 2013. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Signature Estate & Investment Advisors held 38,803 shares of Pfizer worth $934K as of Q2 2026.
- Signature Estate & Investment Advisors bought 14,196 Pfizer shares in Q2 2026, an estimated $371K.
- Pfizer made up 0.02% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #280 holding.
- Signature Estate & Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
- Signature Estate & Investment Advisors's Pfizer position peaked at $3.09M in Q2 2013.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.